Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annie Stevenson
Institution:
VenatoRx Pharmaceuticals (United States)
Observed institution:
VenatoRx Pharmaceuticals (United States)
ORCID:
0009-0009-0737-3209
Observed ORCID:
0009-0009-0737-3209
OpenAlex ID:
A5109023005
Cefepime–taniborbactam and ceftibuten–ledaborbactam maintain activity against KPC variants that lead to ceftazidime–avibactam resistance
2025
·
Cullen L. Myers
, Annie Stevenson
, et al.
·
Antimicrobial Agents and Chemotherapy
·
15
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli strains
2025
·
Tsuyoshi Uehara
, Cassandra L. Chatwin
, et al.
·
Antimicrobial Agents and Chemotherapy
·
10
Impact of porin deletions on cefepime-taniborbactam activity against Klebsiella pneumoniae
2025
·
Tsuyoshi Uehara
, Cassandra L. Chatwin
, et al.
·
Antimicrobial Agents and Chemotherapy
·
6
A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae
2026
·
Tsuyoshi Uehara
, Allison L. Zulli
, et al.
·
Nature Microbiology
·
4
PDF
Show more works
View as search
Works count:
4
Citation count:
35
H-index:
4
I10-index:
2
Year
Topic
Type
